SABS

SAB Biotherapeutics Inc. is a pioneering biopharmaceutical firm dedicated to developing advanced immunotherapies for infectious diseases, autoimmune disorders, and oncology. Based in Sioux Falls, South Dakota, with a significant presence in Cambridge, Massachusetts, the company employs its proprietary technology platform to generate fully human therapeutic antibodies from genetically engineered cows. This innovative approach enables SAB Biotherapeutics to tackle critical health challenges and deliver novel therapeutic solutions in areas with substantial unmet medical needs, solidifying its role as a leader in the biotherapeutics sector.